New R&D base for James Robinson
James Robinson Speciality Ingredients (JRSI) has launched a dedicated 186 m2 biotechnology R&D facility in Manchester. The Biotome division “will significantly extend the company’s research capabilities and production capacity, as it looks to explore more sustainable biotechnology ingredients”, JRSI said.
This follows a management buyout of the James Robinson heritage brand for the part making ingredients for the personal care and photochromics industries in 2019. The original firm had been based in Huddersfield since 1940, making ingredients for the hair colourant, cosmetics and ophthalmic industries until being acquired by India’s Vivimed Labs in 2008.
RELATED ARTICLES
UK-based speciality chemicals company Elementis has announced that, by mutual agreement, CEO Paul Waterman will step down no later than the AGM in April 2025, remaining available as required for any transition or other support until the end of July. A successor is now being sought.
Swiss CDMO Siegfried has inaugurated its new global R&D centre for drug substances at its site in Evionnaz.
International Chemical Investors Group (ICIG), the owner of WeylChem and many other European chemical assets, has acquired the European Advanced Organics business of Valtris Specialty Chemicals.
SOCMA, the trade association of the US speciality chemical manufacturing industry, has published an open letter to the pending Trump administration, urging it to “prioritise policies that encourage advancement, streamline regulatory processes and incentivise domestic manufacturing”.
BASF has formed a partnership with Slovenian white biotech Acies Bio. Under this it will further develop the latter’s OneCarbonBio fermentation platform to derive methanol for the production of fatty alcohols for home and personal care ingredients, notably surfactants.
Peptides CDMO AmbioPharm, has broken ground on a 650 m2, $28 million expansion project at its Shanghai manufacturing site. This is due to be complete in 2H 2025 and will produce over 8 tonnes/year of crude peptide.
